A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.

Nat Genet 2012 Oct 26;44(10):1122-5. Epub 2012 Aug 26.

Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Variants at 8q24.21 have been shown to be associated with glioma development. By means of tag SNP genotyping and imputation, pooled next-generation sequencing using long-range PCR and subsequent validation SNP genotyping, we identified seven low-frequency SNPs at 8q24.21 that were strongly associated with glioma risk (P=1×10(-25) to 1×10(-14)). The most strongly associated SNP, rs55705857, remained highly significant after individual adjustment for the other top six SNPs and two previously published SNPs. After stratifying by histological and tumor genetic subtype, the most significant associations of rs55705857 were with oligodendroglial tumors and gliomas with mutant IDH1 or IDH2 (odds ratio (OR)=5.1, P=1.1×10(-31) and OR=4.8, P=6.6×10(-22), respectively). Strong associations were observed for astrocytomas with mutated IDH1 or IDH2 (grades 2-4) (OR=5.16-6.66, P=4.7×10(-12) to 2.2×10(-8)) but not for astrocytomas with wild-type IDH1 and IDH2 (smallest P=0.26). The conserved sequence block that includes rs55705857 is consistently modeled as a microRNA.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600846PMC
October 2012
169 Reads
44 Citations
29.352 Impact Factor

Publication Analysis

Top Keywords

idh1 idh2
16
8q2421 associated
12
associated glioma
8
oligodendroglial tumors
8
snp genotyping
8
associations rs55705857
4
subtype associations
4
tumor genetic
4
genetic subtype
4
rs55705857 oligodendroglial
4
gliomas mutant
4
ratio or=51
4
odds ratio
4
idh2 odds
4
mutant idh1
4
tumors gliomas
4
stratifying histological
4
rs55705857 remained
4
remained highly
4
snp rs55705857
4

Altmetric Statistics

References

(Supplied by CrossRef)

S Shete et al.
Nat. Genet. 2009

RB Jenkins et al.
Cancer Genet. 2011

M Sanson et al.
Hum. Mol. Genet. 2011

T Rice et al.
Neuro-oncol. 2011

H Yan et al.
N. Engl. J. Med. 2009

BC Christensen et al.
J. Natl. Cancer Inst. 2011

C Houillier et al.
Neurology 2010

MJ van den Bent et al.
Clin. Cancer Res. 2010

C Hartmann et al.
Acta Neuropathol. 2009

G Cairncross et al.
J. Clin. Oncol. 2006

A Idbaih et al.
J. Neurooncol. 2011

Similar Publications